Literature DB >> 27487970

Corrigendum: Generation of stem cell-derived β-cells from patients with type 1 diabetes.

Jeffrey R Millman, Chunhui Xie, Alana Van Dervort, Mads Gürtler, Felicia W Pagliuca, Douglas A Melton.   

Abstract

Entities:  

Year:  2016        PMID： 27487970      PMCID： PMC4976199          DOI： 10.1038/ncomms12379

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


× No keyword cloud information.
The source of reagents for this Article was not fully acknowledged. The Acknowledgements should have included the following: ‘We thank Professors Robin Goland and Dieter Egli (https://www.cellhub.org) for patient fibroblasts.'
  9 in total

1.  Quantifying the Vasculogenic Potential of Induced Pluripotent Stem Cell-Derived Endothelial Progenitors in Collagen Hydrogels.

Authors:  Cody O Crosby; Deepti Valliappan; David Shu; Sachin Kumar; Chengyi Tu; Wei Deng; Sapun H Parekh; Janet Zoldan
Journal:  Tissue Eng Part A       Date:  2019-05-02       Impact factor: 3.845

2.  Translational Research Symposium-collaborative efforts as driving forces of healthcare innovation.

Authors:  João Q Coentro; Andrea De Pieri; Diana Gaspar; Dimitrios Tsiapalis; Dimitrios I Zeugolis; Yves Bayon
Journal:  J Mater Sci Mater Med       Date:  2019-12-02       Impact factor: 3.896

3.  Human beta cells generated from pluripotent stem cells or cellular reprogramming for curing diabetes.

Authors:  Lauren N Randolph; Agamoni Bhattacharyya; Xiaojun Lance Lian
Journal:  Regen Eng Transl Med       Date:  2018-10-08

Review 4.  Modeling Type 1 Diabetes Using Pluripotent Stem Cell Technology.

Authors:  Kriti Joshi; Fergus Cameron; Swasti Tiwari; Stuart I Mannering; Andrew G Elefanty; Edouard G Stanley
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

Review 5.  iPSC technology-based regenerative therapy for diabetes.

Authors:  Yasushi Kondo; Taro Toyoda; Nobuya Inagaki; Kenji Osafune
Journal:  J Diabetes Investig       Date:  2017-07-29       Impact factor: 4.232

6.  Point mutations in the PDX1 transactivation domain impair human β-cell development and function.

Authors:  Xianming Wang; Michael Sterr; Ingo Burtscher; Anika Böttcher; Julia Beckenbauer; Johanna Siehler; Thomas Meitinger; Hans-Ulrich Häring; Harald Staiger; Filippo M Cernilogar; Gunnar Schotta; Martin Irmler; Johannes Beckers; Christopher V E Wright; Mostafa Bakhti; Heiko Lickert
Journal:  Mol Metab       Date:  2019-03-20       Impact factor: 7.422

Review 7.  Endogenous Pancreatic β Cell Regeneration: A Potential Strategy for the Recovery of β Cell Deficiency in Diabetes.

Authors:  Fan Zhong; Yan Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-20       Impact factor: 5.555

Review 8.  Stem/progenitor cells in normal physiology and disease of the pancreas.

Authors:  Mario Enrique Alvarez Fallas; Sergio Pedraza-Arevalo; Ana-Maria Cujba; Teodora Manea; Christopher Lambert; Rosario Morrugares; Rocio Sancho
Journal:  Mol Cell Endocrinol       Date:  2021-09-20       Impact factor: 4.102

Review 9.  Human Pluripotent Stem Cells Go Diabetic: A Glimpse on Monogenic Variants.

Authors:  Sandra Heller; Michael Karl Melzer; Ninel Azoitei; Cécile Julier; Alexander Kleger
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.